Literature DB >> 21411785

The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.

Sara E Monaco1, Yongli Shuai, Mona Bansal, Alyssa M Krasinskas, Sanja Dacic.   

Abstract

Two promising ancillary tests used in the diagnosis of mesothelioma include GLUT-1 immunohistochemical analysis and fluorescence in situ hybridization (FISH) testing for the p16 deletion. This study compared the diagnostic usefulness of p16 FISH and GLUT-1 immunohistochemical analysis in the diagnosis of mesothelial proliferations in 158 cases with a diagnosis of benign (45.4%), atypical (10.4%), or malignant/mesothelioma (44.2%). Of the 70 benign cases, none had a deletion of p16 and 5 cases (7%) were positive for GLUT-1. Of the 68 mesotheliomas, 40 (59%) had a deletion of p16 (sensitivity, 59%; specificity, 100%) and 27 (40%) were positive for GLUT-1 (sensitivity, 40%; specificity, 93%). GLUT-1 showed lower sensitivity in pleural (56% vs 70%) and peritoneal (29% vs 51%) mesotheliomas (P = .004). Our results demonstrate that p16 FISH is a more sensitive and specific test than GLUT-1 immunohistochemical analysis and can be a more reliable ancillary tool to support the diagnosis of mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411785     DOI: 10.1309/AJCPP5R2ZJZKCLWN

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  21 in total

1.  A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction.

Authors:  Russell Fernandes; Shravan Nosib; Dorothy Thomson; Nick Baniak
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma.

Authors:  Jing Liu; Xuanzhi Liao; Yingying Gu; Lin Fu; Jin Zhao; Longguang Li; Zhucheng Chen; Juhong Jiang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  [Mesothelial proliferation in rectal cancer].

Authors:  P Adam; C Schraml; B Sipos; F Fend
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 4.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 5.  Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.

Authors:  Rossella Bruno; Greta Alì; Gabriella Fontanini
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

6.  BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

Authors:  Marta Cigognetti; Silvia Lonardi; Simona Fisogni; Piera Balzarini; Vilma Pellegrini; Andrea Tironi; Luisa Bercich; Mattia Bugatti; Giulio Rossi; Bruno Murer; Mattia Barbareschi; Silvia Giuliani; Alberto Cavazza; Gianpietro Marchetti; William Vermi; Fabio Facchetti
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

Review 7.  Pathological and molecular biological approaches to early mesothelioma.

Authors:  Tohru Tsujimura; Ikuko Torii; Ayuko Sato; Misa Song; Kazuya Fukuoka; Seiki Hasegawa; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

8.  Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.

Authors:  Shinji Matsumoto; Kazuki Nabeshima; Makoto Hamasaki; Tatsuki Shibuta; Tsukuru Umemura
Journal:  Med Oncol       Date:  2014-10-31       Impact factor: 3.064

9.  Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Authors:  Andrew Churg; Richard Attanoos; Alain C Borczuk; Lucian R Chirieac; Françoise Galateau-Sallé; Allen Gibbs; Douglas Henderson; Victor Roggli; Valerie Rusch; Meagan J Judge; John R Srigley
Journal:  Arch Pathol Lab Med       Date:  2016-03-31       Impact factor: 5.534

Review 10.  Diffuse hyperplastic mesothelial cells in multiple lymph nodes: case report with review of the literature.

Authors:  Libo Peng; Qin Shen; Xia Liu; Jiandong Wang; Shanshan Shi; Bo Yu; Xiaojun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.